AI targets early risk: Researchers used AI to analyze ECGs from nearly 6,000 Kenyan patients, identifying early heart function impairment linked to heart failure. High accuracy rates: The AI-ECG ...

Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...

Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced ...

Treatment with treprostinil led to significant and sustained improvements in children with PH associated with lung disease, ...

A TEENAGER whose seizures were dismissed by doctors as anxiety has been left brain damaged and unable to speak or move after ...

FDA approval targets NRG1 fusion–positive advanced cholangiocarcinoma, expanding biomarker-driven options beyond more common FGFR2 and IDH1 alterations. Zenocutuzumab delivered a 36.8% ORR in the ...

Researchers report results from a post hoc analysis evaluating the treatment response of sibeprenlimab vs placebo across different proteinuria thresholds in patients with IgA nephropathy.

Swimming beats running for strengthening the heart, according to new research. Training in water promotes “more robust and ...

Depression is prevalent among patients with CKD including those on dialysis. How depressive symptoms may affect cardiac structure and function has been underexplored.

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing ...